Home
Sigalon - The Swedish Frog's Library tagged → View Popular
20 Dec 08
UCB receives U.S. FDA Complete Response Letter for Neupro(R) in Restless Legs Syndrome and Advanced Parkinson's disease - MSNBC Wire Services - msnbc.com
UCB announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for its transdermal patch, Neupro® (rotigotine transdermal system) to treat the signs and symptoms of advanced Parkinson's disease, and as a treatment for the signs and symptoms of moderate to severe primary Restless Legs Syndrome (RLS).
1 - 1 of 1
Showing 20▼ items per page
Sponsored Links
Ads by Google
Highlighter, Sticky notes, Tagging, Groups and Network: integrated suite dramatically boosting research productivity. Learn more »
Join Diigo